KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on ...

KORU Medical Systems, Inc.KRMD recently announced that it has submitted a 510(k) premarket notification for FDA clearance to ...

KORU Medical aims to broaden FreedomEDGE use beyond immunoglobulin indications to reach the oncology infusion centre market.

Starton Holdings plans $40M IPO for cancer drug delivery innovations, but weak IP and limited backing make this a potentially risky investment. Learn more about STA stock here.

The global auto-injectors market is rapidly evolving, emerging as one of the most dynamic segments of medical devices and pharmaceutical delivery systems. According to a FutureWise Research analysis, ...

In the realm of modern medicine, RNA-based therapies have emerged as a promising avenue, with significant advancements in metabolic diseases ...

Explore how nanotechnology acts as the 'Convergence Engine' for AI materials discovery, CRISPR gene therapy delivery, and ...

Unlike clinical-grade stimulators that require medical supervision or invasive procedures, Pulsetto is positioned within the ...

J&J wins FDA approval for TRUFILL system to treat chronic subdural hematoma via middle meningeal artery embolization.

A team led by Professor Guosheng Tang from Guangzhou Medical University, Associate Professor Yutao Liu from Tianjin University, and Professor Bin Liu ...

Javadin is a berry-flavored, clear, colorless oral solution. Each 5 mL delivers 0.1 mg of clonidine (0.02 mg/mL). Javadin may be used alone or in combination with other antihypertensive agents.

Javadin is a berry-flavored, clear, colorless oral solution. Each 5 mL delivers 0.1 mg of clonidine (0.02 mg/mL). Javadin may be used alone or in combination with other antihypertensive agents.